Skip to main content
Log in

Evaluation of a morpholinothiolporphyrin for use in photodynamic therapy

  • Experimental Oncology
  • Published:
British Journal of Cancer Submit manuscript

Abstract

The photonecrotic effectiveness of a morpholinothiolporphyrin derived from haematoporphyrin was measured in an animal model of cerebral glioma. The dose administered was 20 mg kg-1 and the laser dose varied from 0 to 200 J cm-2. The tumour necrosis was at least as good as that of HpD, and this therapeutic response may be attributed to the targeting of specific 'photopotent' subcellular sites.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Woodburn, K., Hill, J., Stylli, S. et al. Evaluation of a morpholinothiolporphyrin for use in photodynamic therapy. Br J Cancer 70, 398–400 (1994). https://doi.org/10.1038/bjc.1994.316

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1994.316

  • Springer Nature Limited

This article is cited by

Navigation